<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-18589" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Breast Milk Jaundice</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Bratton</surname>
            <given-names>Stephanie</given-names>
          </name>
          <aff>Palms West Hospital/PBCGME</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Cantu</surname>
            <given-names>Rebecca M.</given-names>
          </name>
          <aff>University of Arkansas for Medical Sciences</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Stern</surname>
            <given-names>Mitchell</given-names>
          </name>
          <aff>Plantation General Hospital</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Stephanie Bratton declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Rebecca Cantu declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Mitchell Stern declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>17</day>
          <month>1</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-18589.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Breast milk jaundice is a type of jaundice that occurs in neonates due to breastfeeding. It happens within the first week of life due to the abnormal accumulation of bilirubin, causing a yellowish discoloration to the neonate's skin known as jaundice. This activity reviews the evaluation and treatment of breast milk jaundice and explains interprofessional team members' role in managing patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the etiology of breast milk jaundice.</p></list-item><list-item><p>Review the pathophysiology of breast milk jaundice.</p></list-item><list-item><p>Identify the use of phototherapy in the management of patients with breast milk jaundice.</p></list-item><list-item><p>Outline the importance of collaboration and communication among the interprofessional team to improve outcomes for patients affected by breast milk jaundice.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=18589&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=18589">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-18589.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Jaundice, also known as hyperbilirubinemia, is a frequently encountered clinical problem in neonates. About 60-80% of all term or late-term healthy newborns will develop some degree of hyperbilirubinemia.<xref ref-type="bibr" rid="article-18589.r1">[1]</xref>&#x000a0;The definition of neonatal hyperbilirubinemia has typically been total serum bilirubin (TSB) levels within the high-risk zone or greater than the 95th percentile for age within the first six days of life.<xref ref-type="bibr" rid="article-18589.r1">[1]</xref>&#x000a0;When total serum bilirubin levels rise, a yellowish discoloration of the infant&#x02019;s skin and sclera occurs and is referred to as jaundice. Neonatal hyperbilirubinemia has a higher frequency in breastfed infants compared to formula-fed infants.<xref ref-type="bibr" rid="article-18589.r2">[2]</xref>&#x000a0;The two common mechanisms for this are &#x0201c;breastfeeding jaundice&#x0201d; and &#x0201c;breast milk jaundice.&#x0201d; See <bold>Image.</bold> Bilirubin&#x000a0;Metabolism and&#x000a0;Suggested&#x000a0;Mechanisms of&#x000a0;Breast&#x000a0;Milk Jaundice.</p>
        <p>Breast milk jaundice was first described in 1963. Arias et al. noted that some breastfed infants had unconjugated hyperbilirubinemia that persisted beyond the third week of life. <xref ref-type="bibr" rid="article-18589.r3">[3]</xref>&#x000a0;Breast milk jaundice typically presents in the first or second week of life and usually spontaneously resolves even without discontinuation of breastfeeding. However, it can persist for 8-12 weeks of life before resolution.<xref ref-type="bibr" rid="article-18589.r2">[2]</xref>&#x000a0;Infants with breast milk jaundice often have higher serum bilirubin peaks and slower decline, compared to the hyperbilirubinemia trend associated with other etiologies, leading to a longer resolution time.<xref ref-type="bibr" rid="article-18589.r4">[4]</xref>&#x000a0;Pathological causes of unconjugated hyperbilirubinemia should be ruled out before a breast milk jaundice diagnosis can be made.</p>
      </sec>
      <sec id="article-18589.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The exact etiology of breast milk jaundice has not been determined. Most of the proposed etiologies involve the factors present in the human breast milk itself. Other hypotheses suggest potential genetic mutations present in the affected neonates.</p>
        <p>Some human breast milk factors that may be related to breast milk jaundice's etiology include pregnane-3a,20&#x000df;-diol, interleukin IL1&#x000df;, &#x000df;-glucuronidase, epidermal growth factor, and alpha-fetoprotein.<xref ref-type="bibr" rid="article-18589.r5">[5]</xref>&#x000a0;The presence of pregnane-3a,20&#x000df;-diol, is thought to inhibit bilirubin's conjugation, which in turn impedes bilirubin excretion. &#x000df;-glucuronidase is an enzyme naturally present in the body that deconjugates bilirubin in the intestinal brush border, leading to increased serum reabsorption instead of excretion.<xref ref-type="bibr" rid="article-18589.r2">[2]</xref>&#x000a0;Studies have shown that this enzyme's activity within formula milk is negligible, but it is considerable in human breast milk.<xref ref-type="bibr" rid="article-18589.r6">[6]</xref>&#x000a0;Interleukine IL1&#x000df; is thought to have a cholestatic effect that leads to hyperbilirubinemia.<xref ref-type="bibr" rid="article-18589.r5">[5]</xref>&#x000a0;The epidermal growth factor is present in higher concentrations in human breast milk and strictly breastfed infants' serum. The reason is that this substance enhances intestinal resorption of bilirubin and reduces intestinal motility in the neonatal period, leading to increased unconjugated bilirubin levels.<xref ref-type="bibr" rid="article-18589.r2">[2]</xref>The serum of babies with breast milk jaundice often has elevated levels of alpha-fetoprotein. The mechanism underlying this is not yet understood.</p>
        <p>Several studies have shown that mutations in the coding region of the UGT1A1 gene increase the risk of developing breast milk jaundice. Mutations in this gene's regulatory region are known to cause Crigler-Najjar and Gilbert syndrome, two syndromes known to cause persistent hyperbilirubinemia<xref ref-type="bibr" rid="article-18589.r7">[7]</xref>.</p>
      </sec>
      <sec id="article-18589.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The frequency of breast milk jaundice within the United States is about 20 to 30% of neonates who are mostly breastfed.<xref ref-type="bibr" rid="article-18589.r8">[8]</xref>&#x000a0;About 30-40% of breastfed infants are expected to have bilirubin levels greater than or equal to 5 mg/dL, with about 2 to 4% of exclusively breastfed infants having bilirubin levels above 10 mg/dL in week 3 of life.<xref ref-type="bibr" rid="article-18589.r1">[1]</xref>&#x000a0;International studies in countries such as Turkey and Taiwan found that 20 to 28% of neonates had breast milk jaundice present at four weeks. Total serum bilirubin levels were also noted to be greater than or equal to 5 mg/dL.<xref ref-type="bibr" rid="article-18589.r7">[7]</xref>&#x000a0;The international frequency of breast milk jaundice is not extensively reported but is thought to be similar to the United States frequency. No reports exist demonstrating a sex-related higher incidence.</p>
      </sec>
      <sec id="article-18589.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Before discussing the mechanism for breast milk jaundice, it is crucial to understand neonatal bilirubin metabolism and why neonates, in general, are affected by hyperbilirubinemia. Newborns have markedly increased bilirubin production compared to their adult counterparts, secondary to a higher blood volume and hemoglobin concentration, a shorter red blood cell lifespan, and liver enzymes' physiological immaturity. These factors combined result in relatively high production of unconjugated form, which is not water-soluble. To excrete bilirubin from the body, there is the conversion of the unconjugated form to the conjugated (water-soluble) form is required. The conjugation process occurs within the hepatocyte by bilirubin uridine diphosphate glucuronosyltransferase (bilirubin-UGT) enzyme. UGT1A1 gene codes this enzyme production. Therefore those with genetic mutations in this gene are unable to conjugate bilirubin adequately. This enzyme is also significantly less active in neonates than in adults, leading to less efficient conjugation. After conjugation and excretion from hepatocytes, the bilirubin passes to the small intestine, where it gets converted to stercobilin by gut flora and subsequently excreted via the stool.&#x000a0;</p>
        <p>Infants have a decreased concentration of gut flora needed for this process than adults, leading to a higher concentration of bilirubin remaining within the intestinal tract. The enzyme &#x000df;-glucuronidase will deconjugate bilirubin remaining within the intestine. After this process, it is returned to the liver for re-conjugation via portal circulation. This process is known as "enterohepatic circulation." Neonates have significantly higher activity of the enzyme &#x000df;-glucuronidase and a more permeable gut wall, leading to overall higher concentrations of unconjugated bilirubin and increased enterohepatic circulation.<xref ref-type="bibr" rid="article-18589.r2">[2]</xref>&#x000a0;</p>
        <p>Basic and clinical studies were conducted and are still ongoing to investigate breast milk jaundice's pathophysiology by studying breast milk's effect on the processes discussed above.<xref ref-type="bibr" rid="article-18589.r9">[9]</xref><xref ref-type="bibr" rid="article-18589.r10">[10]</xref>&#x000a0;A visual summary of bilirubin metabolism and suggested mechanisms of breast milk jaundice is shown in figure 1.</p>
      </sec>
      <sec id="article-18589.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Breast milk jaundice typically presents within the first two weeks of life in an otherwise healthy infant who is predominantly breastfed. These infants exhibit normal weight gain with adequate production of urine and stools.<xref ref-type="bibr" rid="article-18589.r2">[2]</xref>. A total serum bilirubin level above 1.5 mg/dL is considered elevated at this time, but most infants will not appear jaundiced unless the level is above 5 mg/dL. If the infant does appear jaundiced, this yellowish discoloration of their skin and/or sclera is typically first noted in the face and then proceeds to the trunk and extremities.</p>
      </sec>
      <sec id="article-18589.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The evaluation of a patient presenting with hyperbilirubinemia must include a work-up to rule out pathological causes of hyperbilirubinemia before making the breast milk jaundice diagnosis. First, both unconjugated and conjugated bilirubin levels must be measured. Conjugated bilirubin levels higher than 1 mg/dL or 20% of the total bilirubin level indicate conjugated hyperbilirubinemia (also known as cholestasis or direct hyperbilirubinemia). Once cholestasis is suspected, disorders such as biliary atresia, neonatal hepatitis, and other bilirubin excretion disorders. Both breast milk jaundice and hemolytic anemias cause elevated unconjugated bilirubin levels. Hemolytic causes for hyperbilirubinemia include ABO incompatibility, G6PD deficiency, hereditary spherocytosis, and other antibody-mediated hemolysis. Hemolysis assessment should consist of direct Coombs&#x02019; testing, measurement of hemoglobin, hematocrit, and reticulocyte count, a peripheral blood smear, and genetic testing.</p>
        <p>The clinician should consider other non-hemolytic causes of prolonged hyperbilirubinemia, such as Crigler-Najjar or Gilbert syndrome but need not investigate them unless jaundice persists longer than what is expected for breast milk jaundice. Galactosemia and hypothyroidism can also cause unconjugated hyperbilirubinemia, hence should be ruled out.<xref ref-type="bibr" rid="article-18589.r2">[2]</xref><xref ref-type="bibr" rid="article-18589.r11">[11]</xref></p>
      </sec>
      <sec id="article-18589.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treatment is not necessary for breast milk jaundice unless the infant's total serum bilirubin level is greater than the phototherapy guidelines recommended by the American Academy of Pediatrics (AAP).<xref ref-type="bibr" rid="article-18589.r12">[12]</xref>&#x000a0;The first step of management is phototherapy. It works by using light to convert bilirubin molecules into water-soluble isomers that the body can excrete. If the total serum bilirubin level remains below 12 mg/dL, the recommendation is to continue breastfeeding. If the total serum bilirubin level is higher than 12 mg/dL but below the phototherapy level, and further investigation shows no hemolysis evidence, the recommendations are also to continue breastfeeding.<xref ref-type="bibr" rid="article-18589.r2">[2]</xref>&#x000a0;When the bilirubin is greater than 20, a brief 24-hour cessation of breastfeeding may be beneficial.&#x000a0;</p>
      </sec>
      <sec id="article-18589.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Differential diagnosis of breast milk jaundice include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Physiological jaundice of newborns</p>
          </list-item>
          <list-item>
            <p>Hemolysis associated hyperbilirubinemia ( ABO, G6PD, hereditary spherocytosis, others)</p>
          </list-item>
          <list-item>
            <p>Breastfeeding jaundice ( inadequate milk intake and dehydration)</p>
          </list-item>
          <list-item>
            <p>Genetic causes ( Crigler-Najjar, pyruvate kinase deficiency, and Gilbert syndromes)</p>
          </list-item>
          <list-item>
            <p>Cholestasis (Biliary atresia, neonatal hepatitis, choledochal cyst, and disorders of bilirubin excretion)</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-18589.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Overall, infants' prognosis with breast milk jaundice is excellent as it is a self-limited condition that usually resolves around 12 weeks of age.</p>
      </sec>
      <sec id="article-18589.s11" sec-type="Complications">
        <title>Complications</title>
        <p>The most feared complication of all neonatal hyperbilirubinemia, including breast milk jaundice, is acute bilirubin encephalopathy acutely and kernicterus (chronic bilirubin encephalopathy) in the long term. This concern is due to its potential for permanent neurodevelopmental delay. It is a rare complication of breast milk jaundice and occurs in less than 2% of breastfed term infants who have no evidence of hemolytic anemia.<xref ref-type="bibr" rid="article-18589.r13">[13]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-18589.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Parents of affected infants should be educated about the nature of breast milk jaundice and the expected clinical course. The mother of the affected newborn should continue to breastfeed unless otherwise contraindicated.<xref ref-type="bibr" rid="article-18589.r9">[9]</xref><xref ref-type="bibr" rid="article-18589.r14">[14]</xref></p>
      </sec>
      <sec id="article-18589.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Although jaundice in breastfed infants is a common and usually benign finding, it cannot be ignored. Clear communication between all healthcare team members and the parents is necessary to provide medical guidance and rule out other neonatal hyperbilirubinemia causes. With routine newborn evaluation and timely management, kernicterus, the most severe complication of neonatal hyperbilirubinemia, is preventable, and the successful continuation of breastfeeding is possible.</p>
      </sec>
      <sec id="article-18589.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=18589&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=18589">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/child-health/breast-milk-jaundice/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=18589">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/18589/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=18589">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-18589.s15">
        <fig id="article-18589.image.f1" position="float" orientation="portrait">
          <caption>
            <p>&#x000a0;Bilirubin Metabolism and Suggested Mechanisms of Breast Milk Jaundice Contributed by M Alsaleem, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Figure__1__for__breast__milk__jaundice" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-18589.s16">
        <title>References</title>
        <ref id="article-18589.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ullah</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rahman</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hedayati</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Hyperbilirubinemia in Neonates: Types, Causes, Clinical Examinations, Preventive Measures and Treatments: A Narrative Review Article.</article-title>
            <source>Iran J Public Health</source>
            <year>2016</year>
            <month>May</month>
            <volume>45</volume>
            <issue>5</issue>
            <fpage>558</fpage>
            <page-range>558-68</page-range>
            <pub-id pub-id-type="pmid">27398328</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18589.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Preer</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Philipp</surname>
                <given-names>BL</given-names>
              </name>
            </person-group>
            <article-title>Understanding and managing breast milk jaundice.</article-title>
            <source>Arch Dis Child Fetal Neonatal Ed</source>
            <year>2011</year>
            <month>Nov</month>
            <volume>96</volume>
            <issue>6</issue>
            <fpage>F461</fpage>
            <page-range>F461-6</page-range>
            <pub-id pub-id-type="pmid">20688866</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18589.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>ARIAS</surname>
                <given-names>IM</given-names>
              </name>
              <name>
                <surname>GARTNER</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>SEIFTER</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>FURMAN</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>PROLONGED NEONATAL UNCONJUGATED HYPERBILIRUBINEMIA ASSOCIATED WITH BREAST FEEDING AND A STEROID, PREGNANE-3(ALPHA), 20(BETA)-DIOL, IN MATERNAL MILK THAT INHIBITS GLUCURONIDE FORMATION IN VITRO.</article-title>
            <source>J Clin Invest</source>
            <year>1964</year>
            <month>Nov</month>
            <volume>43</volume>
            <issue>11</issue>
            <fpage>2037</fpage>
            <page-range>2037-47</page-range>
            <pub-id pub-id-type="pmid">14228539</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18589.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Auerbach</surname>
                <given-names>KG</given-names>
              </name>
              <name>
                <surname>Gartner</surname>
                <given-names>LM</given-names>
              </name>
            </person-group>
            <article-title>Breastfeeding and human milk: their association with jaundice in the neonate.</article-title>
            <source>Clin Perinatol</source>
            <year>1987</year>
            <month>Mar</month>
            <volume>14</volume>
            <issue>1</issue>
            <fpage>89</fpage>
            <page-range>89-107</page-range>
            <pub-id pub-id-type="pmid">3549117</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18589.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Soldi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tonetto</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Varalda</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bertino</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Neonatal jaundice and human milk.</article-title>
            <source>J Matern Fetal Neonatal Med</source>
            <year>2011</year>
            <month>Oct</month>
            <volume>24 Suppl 1</volume>
            <fpage>85</fpage>
            <page-range>85-7</page-range>
            <pub-id pub-id-type="pmid">21942599</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18589.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>el-Kholy</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Halim</surname>
                <given-names>HY</given-names>
              </name>
              <name>
                <surname>Marzouk</surname>
                <given-names>AH</given-names>
              </name>
            </person-group>
            <article-title>Beta-glucuronidase and hyperbilirubinemia in breast-fed versus formula-fed babies.</article-title>
            <source>J Egypt Public Health Assoc</source>
            <year>1992</year>
            <volume>67</volume>
            <issue>3-4</issue>
            <fpage>237</fpage>
            <page-range>237-48</page-range>
            <pub-id pub-id-type="pmid">1296961</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18589.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maruo</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Morioka</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Fujito</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Nakahara</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yanagi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Matsui</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mori</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sato</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Tukey</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Takeuchi</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Bilirubin uridine diphosphate-glucuronosyltransferase variation is a genetic basis of breast milk jaundice.</article-title>
            <source>J Pediatr</source>
            <year>2014</year>
            <month>Jul</month>
            <volume>165</volume>
            <issue>1</issue>
            <fpage>36</fpage>
            <page-range>36-41.e1</page-range>
            <pub-id pub-id-type="pmid">24650397</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18589.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maisels</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Clune</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Coleman</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Gendelman</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kendall</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>McManus</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Smyth</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>The natural history of jaundice in predominantly breastfed infants.</article-title>
            <source>Pediatrics</source>
            <year>2014</year>
            <month>Aug</month>
            <volume>134</volume>
            <issue>2</issue>
            <fpage>e340</fpage>
            <page-range>e340-5</page-range>
            <pub-id pub-id-type="pmid">25049352</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18589.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Prameela</surname>
                <given-names>KK</given-names>
              </name>
            </person-group>
            <article-title>Breastfeeding during breast milk jaundice - a pathophysiological perspective.</article-title>
            <source>Med J Malaysia</source>
            <year>2019</year>
            <month>Dec</month>
            <volume>74</volume>
            <issue>6</issue>
            <fpage>527</fpage>
            <page-range>527-533</page-range>
            <pub-id pub-id-type="pmid">31929480</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18589.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tukey</surname>
                <given-names>RH</given-names>
              </name>
            </person-group>
            <article-title>Humanized <italic>UGT1</italic> Mice, Regulation of <italic>UGT1A1</italic>, and the Role of the Intestinal Tract in Neonatal Hyperbilirubinemia and Breast Milk-Induced Jaundice.</article-title>
            <source>Drug Metab Dispos</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>46</volume>
            <issue>11</issue>
            <fpage>1745</fpage>
            <page-range>1745-1755</page-range>
            <pub-id pub-id-type="pmid">30093417</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18589.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Poddighe</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Castelli</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Marseglia</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Bruni</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Prolonged, but transient, elevation of liver and biliary function tests in a healthy infant affected with breast milk jaundice.</article-title>
            <source>BMJ Case Rep</source>
            <year>2014</year>
            <month>May</month>
            <day>28</day>
            <volume>2014</volume>
            <pub-id pub-id-type="pmid">24872488</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18589.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <collab>American Academy of Pediatrics Subcommittee on Hyperbilirubinemia</collab>
            <article-title>Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation.</article-title>
            <source>Pediatrics</source>
            <year>2004</year>
            <month>Jul</month>
            <volume>114</volume>
            <issue>1</issue>
            <fpage>297</fpage>
            <page-range>297-316</page-range>
            <pub-id pub-id-type="pmid">15231951</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18589.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Muchowski</surname>
                <given-names>KE</given-names>
              </name>
            </person-group>
            <article-title>Evaluation and treatment of neonatal hyperbilirubinemia.</article-title>
            <source>Am Fam Physician</source>
            <year>2014</year>
            <month>Jun</month>
            <day>01</day>
            <volume>89</volume>
            <issue>11</issue>
            <fpage>873</fpage>
            <page-range>873-8</page-range>
            <pub-id pub-id-type="pmid">25077393</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18589.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ketsuwan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Baiya</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Maelhacharoenporn</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Puapornpong</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>The Association of Breastfeeding Practices with Neonatal Jaundice.</article-title>
            <source>J Med Assoc Thai</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>100</volume>
            <issue>3</issue>
            <fpage>255</fpage>
            <page-range>255-61</page-range>
            <pub-id pub-id-type="pmid">29911780</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
